Mandate

Vinge advises FCG in connection with the acquisition of Algorithmica Research

Vinge has advised Bridgepoint and FCG in connection with the acquisition of Algorithmica Research AB, a software technology provider of risk management and quantitative financial analytical solutions for the financial services industry.

Through the acquisition, FCG, leading Northern European experts in Governance, Risk & Compliance (“GRC”) with a strong track record of providing new and customer centered services to clients in the finance and insurance sector, adds new capabilities to enhance and further expand its technology area and product offerings.

Vinge’s team consisted primarily of partner Daniel Rosvall and associates Michaela Cronemyr, Fredric Reissmüller, Carl Fredrik Wachtmeister (M&A), Lisa Hörnqvist (Commercial Agreements), Lisa Ullman (Employment), Nathalie Hughes (VDR-assistant) also partner Alber Wållgren along with associates Josefin Lanker and Hannes Pettersson (Banking & Financing).

 

Related

Vinge has advised Morrow Bank in connection with its issuances of primary capital instruments (AT1) and tier 2 capital bonds (T2)

The issuances comprised perpetual AT1 bonds of NOK 300 million with a floating coupon of 3-month NIBOR + 425 basis points and a first call date in 2031, as well as subordinated Tier 2 bonds of SEK 200 million with a floating coupon of 3-month STIBOR + 325 basis points and a first call date in 2031. The bonds are intended to be admitted to trading on Nasdaq Stockholm.
July 03, 2026

Vinge advises Wihlborgs Fastigheter in connection with the financing of property acquisition valued at SEK 13.3 billion

Vinge advises Wihlborgs Fastigheter AB (publ) in connection with the financing of the acquisition of all of Castellum’s property holdings in Malmö, Lund and Helsingborg. The financing has been secured through Danske Bank, SEB and Swedbank.
June 29, 2026

Vinge advises Ambea on the public offer for Humana

Ambea AB (publ) has made a public offer for all shares in Humana AB. The offer values all shares in Humana at approximately SEK 2,96 billion. The consideration consists of a mix of shares, cash and a CVR (contingent value right).
June 29, 2026